Print “PDF version”
The Sequential Organ Failure Assessment (SOFA) score was originally developed in 1996. A group of 60 experts has now developed a consensus-based update to the original SOFA score, using a modified Delphi approach (Ranzani 2025, Moreno 2025). The new SOFA-2 score was then validated in 10 international multicenter cohorts of 3.3 million adult ICU patients.
SOFA-2 includes the
original 6 organ systems with a total score ranging from 0 to 24 (higher scores
indicate worse organ dysfunction). The updated score also incorporates commonly
used drugs and mechanical organ supports that were
rarely or not used when the original version was published in 1996. Some
thresholds were modified to improve predictive validity against ICU mortality.
Organ systems included in both SOFA-1 and SOFA-2 are hepatic, renal, cardiac,
respiratory, neurologic, and blood coagulation. The SOFA-2 consensus panel
considered adding immune and gastrointestinal systems
but these were ultimately not able to be included in the new score.
Reclassification
between total SOFA-1 and SOFA-2 occurred for nearly half of the patients
(SOFA-2 was greater in 11% and lower in 40%).
SOFA-2 scores may be
predictive of mortality in ICU patients. An increase in the SOFA-2 score is
correlated with worse ICU outcomes. A 1-unit increase in SOFA-2 was associated
with an increase in the odds of ICU mortality of 38% (odds ratio, 1.378).
Actually,
a better title for this
column could have been “SOFA-2: A Score in Search of an Application”. The SOFA
score has been utilized in clinical trials, but it really hasn’t caught on as a
clinical tool to use daily. Seymour, in an editorial accompanying the
Ranzani paper (Seymour 2025),
states “The SOFA score, despite its many applications, is yet to become a
bedside tool, discussion topic on ICU rounds, or a score that directly
influences clinical practice.” But he does note that organ failure scores are still incorporated into contemporary risk
prediction models, syndromic criteria like Sepsis-3, and disaster triage tools
and are also used to compare ICU populations and outcomes from randomized
clinical trials. He also says that organ failure scores are used widely by
clinicians, researchers, and quality improvement teams.
We did note that the SOFA score was used in development of a new definition of sepsis (see our March 2016 What's New in the Patient Safety World column “Finally…A More Rational Definition for Sepsis”). But it certainly has had limited applicability in clinical practice. Moreno et al. (Moreno 2025) note that the sponsoring bodies of the International Sepsis-3 Definitions should determine whether SOFA-2 should supersede SOFA-1 to better reflect current practices.
References:
Ranzani OT, Singer M, Salluh JIF, et al. Development and Validation of the Sequential Organ Failure Assessment (SOFA)-2 Score. JAMA 2025; 334(23): 2090-2103
https://jamanetwork.com/journals/jama/fullarticle/2840822
Moreno R, Rhodes A, Ranzani O, et al. Rationale and Methodological Approach Underlying the Development of the Sequential Organ Failure Assessment (SOFA)–2 Score: A Consensus Statement. JAMA Netw Open 2025; 8(10): e2545040 Published online October 29, 2025
https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2840786
Seymour CW. A Revision to Organ Failure Assessment in Critically Ill Patients. JAMA 2025; 334(23): 2075-2077
https://jamanetwork.com/journals/jama/fullarticle/2840827
Print “PDF version”
http://www.patientsafetysolutions.com/
What’s New in
the Patient Safety World Archive